sk&f-38393 has been researched along with tamoxifen in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Evans, SL; Johnson, DE; Ochieng, J | 1 |
| Auger, AP; Auger, CJ; Jessen, HM; Olesen, KM | 1 |
2 other study(ies) available for sk&f-38393 and tamoxifen
| Article | Year |
|---|---|
The growth inhibitory properties of a dopamine agonist (SKF 38393) on MCF-7 cells.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Breast Neoplasms; Cell Division; Dopamine Agonists; Estradiol; Haloperidol; Humans; Prolactin; Receptors, Estrogen; Tamoxifen; Tumor Cells, Cultured | 1995 |
Dopaminergic activation of estrogen receptors in neonatal brain alters progestin receptor expression and juvenile social play behavior.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Animals, Newborn; Behavior, Animal; Brain; Dopamine; Dopamine Agonists; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Female; Male; Play and Playthings; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Progesterone; Social Behavior; Tamoxifen | 2005 |